psychedelics

Small Pilot Trial Combining Cognitive Behavioral Therapy (CBT) With Psilocybin Yields Rapid, Significant, and Sustained Relief of Major Depression Symptoms
A research team led by BBRF grantees has published positive results of a small pilot trial that combined several months of cognitive behavioral therapy (CBT) for major depressive disorder (MDD) with… Read More
Inhalable Formulation of Psychedelic Drug Rapidly Helped Patients With Treatment-Resistant Depression in Phase 2 Trial
An international team of researchers has published results of a preliminary clinical trial testing a formulation of 5-MeO-DMT, a potent and rapid-acting psychedelic drug, in patients with treatment-… Read More
Modifying LSD to Minimize Hallucinogenic Properties Results in a Potential New Drug Candidate for Schizophrenia
Some psychedelic compounds have been shown to be powerful promoters of growth in atrophied cortical neurons, a fact that has intrigued researchers interested in addressing one of the hallmark… Read More
Researchers Isolate Distinct Circuits That Confer Hallucinogenic and Anti-Anxiety Effects Following Administration of a Psychedelic Drug
Considerable effort has been made in recent years to evaluate—or in some cases, reevaluate—psychedelic drugs for potential use as therapeutics to treat, among other things, psychiatric disorders such… Read More